Emdeon gets 'Sell' signal

Analyst Bret Jones, with NYC-based Brean Murray Carret & Co., put a Sell rating on Emdeon, Jones' full report is here. The analyst argues the stock has been overvalued by an overly generous association with the Health IT sector, and which is challenged by emerging regional health information exchanges. Only the revenue-cycle portion of Emdeon's business is truly Health IT, said Jones. Analyst Jones, who joined Brean Murray earlier this year, has been talking about Health IT, itself, being overvalued since at least February, when he did this Reuters interview. HT: NashvillePost.com